Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

3.935 UNCHANGED

Streaming Delayed Price Updated: 3:49 PM EDT, Mar 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	3.935
Bid (Size)	3.750 (100)
Ask (Size)	4.360 (100)
Prev. Close	3.935
Today's Range	3.935 - 3.935
52wk Range	3.635 - 11.68
Shares Outstanding	6,356,270
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products

February 17, 2026

Via Investor Brand Network

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

February 17, 2026

From Nutriband Inc.

Via GlobeNewswire

Performance

YTD	-11.2%	-11.2%
1 Month	-7.6%	-7.6%
3 Month	-19.5%	-19.5%
6 Month	-34.4%	-34.4%
1 Year	-35.5%	-35.5%

More News

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting

January 30, 2026

Via Investor Brand Network

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

January 30, 2026

From Nutriband Inc.

Via GlobeNewswire

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2025 Milestones and 2026 Outlook

December 31, 2025

Via Investor Brand Network

Nutriband CEO Publishes Letter to Shareholders

December 31, 2025

From Nutriband Inc.

Via GlobeNewswire

What’s Driving Nutriband Shares Higher Today? ↗

December 29, 2025

Via Stocktwits

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sells 90% Stake in Pocono Pharmaceutical for $5 Million

December 29, 2025

Via Investor Brand Network

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

December 29, 2025

From Nutriband Inc.

Via GlobeNewswire

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs LOI to Explore Quantum-AI Technology Collaboration

December 19, 2025

Via Investor Brand Network

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Responds to Fentanyl WMD Executive Order, Highlights AVERSA(TM) FENTANYL Development

December 18, 2025

Via Investor Brand Network

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

December 18, 2025

From Nutriband Inc.

Via GlobeNewswire

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

December 18, 2025

From Nutriband Inc.

Via GlobeNewswire

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Chairman Presentation at NobleCon21

November 24, 2025

Via Investor Brand Network

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

October 28, 2025

From Nutriband Inc.

Via GlobeNewswire

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission

October 28, 2025

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 28, 2025

Via Benzinga

Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market

October 28, 2025

Via AB Newswire

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

October 28, 2025

From Nutriband Inc.

Via GlobeNewswire

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Founder Gareth Sheridan Returns as CEO to Lead Final Development Phase of AVERSA Fentanyl

October 27, 2025

Via Investor Brand Network

Nutriband Co-Founder Gareth Sheridan Returns as CEO

October 27, 2025

From Nutriband Inc.

Via GlobeNewswire

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Channelchek Report Highlighting AVERSA Fentanyl Progress

October 24, 2025

Via Investor Brand Network

BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Partners with Brand Institute to Develop Global Brand Identity for AVERSA FENTANYL

October 10, 2025

Via Investor Brand Network

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

October 10, 2025

From Nutriband Inc.

Via GlobeNewswire

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Files Provisional Patent to Strengthen Protection of AVERSA(TM) Abuse-Deterrent Technology

October 09, 2025

Via Investor Brand Network

Frequently Asked Questions

Is Nutriband Inc. - Common Stock publicly traded?

Yes, Nutriband Inc. - Common Stock is publicly traded.

What exchange does Nutriband Inc. - Common Stock trade on?

Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Nutriband Inc. - Common Stock?

The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market

What is the current price of Nutriband Inc. - Common Stock?

The current price of Nutriband Inc. - Common Stock is 3.935

When was Nutriband Inc. - Common Stock last traded?

The last trade of Nutriband Inc. - Common Stock was at 03/11/26 03:49 PM ET

What is the market capitalization of Nutriband Inc. - Common Stock?

The market capitalization of Nutriband Inc. - Common Stock is 25.01M

How many shares of Nutriband Inc. - Common Stock are outstanding?

Nutriband Inc. - Common Stock has 25M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.